Ironwood Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 106.5M | 47.7M | 122.1M | 85.2M | 41.1M | 90.5M | 91.6M | 94.4M |
| Cost of Goods Sold | 443K | 0 | 475K | 467K | 27.4M | 0 | 29.8M | 0 |
| Gross Profit | 106.1M | 47.7M | 121.6M | 84.8M | 13.7M | 90.5M | 61.8M | 94.4M |
| R&D Expenses | 21.5M | 21.9M | 22.0M | 22.9M | 27.4M | 25.4M | 29.8M | 30.4M |
| Operating Expenses | 33.5M | 41.2M | 43.9M | 39.7M | 42.8M | 59.1M | 36.1M | 69.4M |
| Operating Income | 72.5M | 6.6M | 77.7M | 45.1M | -29.1M | 31.5M | 25.6M | 25.0M |
| Other Income / Gains | -7.4M | -6.1M | -9.7M | -7.2M | -7.2M | -7.5M | -8.3M | -6.1M |
| Net Income | 40.8M | -2.3M | 40.1M | 23.6M | -37.4M | 2.3M | 3.6M | -860K |
| EPS (Diluted) | 0.25 | -0.014 | 0.25 | 0.15 | -0.23 | 0.014 | 0.023 | -0.005 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.996 | 1.00 | 0.996 | 0.995 | 0.333 | 1.00 | 0.674 | 1.00 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 12.0M | 19.3M | 21.9M | 16.8M | 0 | 33.6M | 36.1M | 37.0M |
| Other Expenses | 0 | 0 | 0 | 0 | 15.4M | 73K | -29.8M | 2.1M |
| Cost And Expenses | 34.0M | 41.2M | 44.4M | 40.2M | 70.3M | 59.1M | 66.0M | 69.4M |
| Interest Income | 1.7M | 1.5M | 930K | 818K | 869K | 778K | 1.2M | 1.4M |
| Interest Expense | 9.1M | 7.9M | 8.4M | 8.4M | 8.1M | 8.9M | 9.4M | 7.5M |
| Depreciation And Amortization | 443K | 460K | 475K | 467K | 479K | 485K | 507K | 506K |
| Ebitda | 73.0M | 8.8M | 78.2M | 45.5M | -10.1M | 33.4M | 27.3M | 26.9M |
| Ebitdaratio | 0.685 | 0.184 | 0.64 | 0.534 | -0.245 | 0.369 | 0.298 | 0.284 |
| Operating Income Ratio | 0.681 | 0.137 | 0.636 | 0.529 | -0.707 | 0.348 | 0.28 | 0.265 |
| Income Before Tax | 65.2M | 455K | 68.0M | 37.8M | -36.3M | 24.0M | 17.4M | 18.9M |
| Income Before Tax Ratio | 0.612 | 0.01 | 0.557 | 0.444 | -0.882 | 0.265 | 0.19 | 0.20 |
| Income Tax Expense | 24.4M | 2.7M | 27.9M | 14.2M | 1.1M | 21.7M | 13.7M | 19.7M |
| Net Income Ratio | 0.383 | -0.048 | 0.328 | 0.277 | -0.909 | 0.025 | 0.04 | -0.009 |
| Epsdiluted | 0.24 | -0.013 | 0.23 | 0.14 | -0.23 | 0.014 | 0.023 | -0.005 |
| Weighted Average Shs Out | 163.5M | 162.2M | 162.2M | 161.7M | 161.0M | 159.9M | 159.7M | 159.0M |
| Weighted Average Shs Out Dil | 166.7M | 177.8M | 177.8M | 161.7M | 161.0M | 160.4M | 160.2M | 159.0M |